Medicine · Hematological Malignancies (Leukemias, Lymphoma, Myeloma, Myeloproliferative)

A 65-year-old man is found to have WBC 145 × 10⁹/L with 92% mature lymphocytes. Flow cytometry shows CD5+, CD19+, CD23+, CD20(dim), sIg(dim), FMC7–. The MOST likely diagnosis is:

  • A Chronic lymphocytic leukemia (CLL)
  • B Mantle cell lymphoma (MCL)
  • C Follicular lymphoma
  • D Prolymphocytic leukemia (PLL)
Correct answer: A. Chronic lymphocytic leukemia (CLL)

Explanation

CLL has the characteristic immunophenotype CD5+, CD19+, CD23+, CD20 (dim), surface Ig (dim), FMC7 negative, and CD22 (dim). This CD23 positivity and FMC7 negativity distinguishes CLL from mantle cell lymphoma, which is CD5+, CD23–, FMC7+, with Cyclin D1 overexpression due to t(11;14). Follicular lymphoma is CD5–. PLL has >55% prolymphocytes with a different clinical picture.

Reference: Harrison's Principles of Internal Medicine, 21st ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Hematological Malignancies (Leukemias, Lymphoma, Myeloma, Myeloproliferative) MCQs

See all Hematological Malignancies (Leukemias, Lymphoma, Myeloma, Myeloproliferative) MCQs →